Abstract
ObjectivesThe objective of this study was to investigate the number of metastatic lymph nodes (pN) and the metastatic lymph node ratio (MLR) on the post-surgical prognosis of Chinese patients with esophageal cancer (EC) and lymph node metastasis.MethodsWe enrolled 353 patients who received primary curative resection for EC from 1990 to 2003. The association of pN and MLR with 5-year overall survival (OS) was examined by receiver operating characteristic (ROC) and area under the curve (AUC) analysis. The Kaplan-Meier method was used to calculate survival rates, and survival curves were compared with the log-rank test. The Cox model was employed for univariate and multivariate analyses of factors associated with 5-year OS.ResultsThe median follow-up time was 41 months, and the 1-, 3- and 5-year OS rates were 71.2%, 30.4%, and 19.5%, respectively. Univariate analysis showed that age, pN stage, and the MLR were prognostic factors for OS. Patients with MLRs less than 0.15, MLRs of 0.15-0.30, and MLRs greater than 0.30 had 5-year OS rates of 30.1%, 17.8%, and 9.5%, respectively (p < 0.001). Patients classified as pN1, pN2, and pN3 had 5-year OS rates of 23.7%, 11.4%, and 9.9%, respectively (p < 0.001). Multivariate analysis indicated that a high MLR and advanced age were significant and independent risk factors for poor OS. Patients classified as pN2 had significantly worse OS than those classified as pN1 (p = 0.022), but those classified as pN3 had similar OS as those classified as pN1 (p = 0.166). ROC analysis indicated that MLR (AUC = 0.585, p = 0.016) had better predictive value than pN (AUC = 0.565, p = 0.068).ConclusionsThe integrated use of MLR and pN may be suitable for evaluation of OS in Chinese patients with EC and positive nodal metastasis after curative resection.
Highlights
Esophageal cancer (EC) has a higher incidence in China than in most Western countries
We retrospectively examined the records of Chinese patients with EC who had lymph node metastasis and received surgical treatment, and compared use of the metastatic lymph node ratio (MLR) with the new American Joint Committee on Cancer (AJCC) staging system for evaluation of prognosis
We compared the use of positive lymph nodes (pN) stage and the MLR for determination of the prognosis of Chinese patients with EC who were positive for lymph node metastasis following radical esophagectomy
Summary
Esophageal cancer (EC) has a higher incidence in China than in most Western countries. There has been great progress in the comprehensive therapy of EC in recent decades, the prognosis of EC patients in China remains poor. The presence of lymph node metastases affects the prognosis of patients with EC. The first edition of the Guidelines for TNM Staging in 1977 staged positive lymph nodes as N1. The seventh edition of the American Joint Committee on Cancer (AJCC) Staging Manual [6] (published in 2010) reclassified EC lymph node metastases so that stage was based on the number of metastatic lymph nodes. Gastric cancer, and colon cancer, poor prognosis in EC was associated with a greater number of metastatic lymph nodes. According to current guidelines for EC, pN1 refers to 1-2 positive lymph nodes, N2 refers to 3-6 positive lymph nodes, and N3 refers to 7 or more positive lymph nodes [6]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.